
The publisher cited slower admissions growth, falling per-share earnings and lower returns as reasons for its cautious view of Acadia Healthcare.
StockStory’s post-Q2 analysis took a cautious view of Acadia Healthcare, citing admissions growth, declining earnings per share and lower returns on invested capital. The publisher said the shares traded at $28.83 in its report.
Acadia recorded 54,141 admissions in the latest quarter, according to StockStory. The publisher said admissions growth averaged 4.5% year over year across the past two years, slightly behind the sector.
StockStory also said Acadia’s EPS fell 12.4% annually over the past five years, while revenue grew 8.7%. It said the company’s return on invested capital had decreased over the past few years, and noted a forward price-to-earnings ratio of 17.1.
This article was produced with the help of AI technology. Source: Yahoo Finance